cetirizine has been researched along with Nervous System Disorders in 1 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gealageas, R | 1 |
| Devineau, A | 1 |
| So, PPL | 1 |
| Kim, CMJ | 1 |
| Surendradoss, J | 1 |
| Buchwalder, C | 1 |
| Heller, M | 1 |
| Goebeler, V | 1 |
| Dullaghan, EM | 1 |
| Grierson, DS | 1 |
| Putnins, EE | 1 |
1 other study available for cetirizine and Nervous System Disorders
| Article | Year |
|---|---|
Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Dogs; Drug Development; Human | 2018 |